Aqualab, retail arm of Laborate Pharmaceuticals India, crossed ₹100 crore revenue in three years and targets ₹250 crore by FY25–26. Its 800+ SKUs and 500+ stockists drive Tier-II/III expansion. MD Arpit Bhatia cites scaling Direct-to-Retail and last-mile delivery. Leveraging Laborate’s GMP-certified facilities, Aqualab eyes exports, digital channels, and new categories in India’s ₹18,700 crore retail pharmacy market, projected at ₹31,200 crore by FY32. Founded 1985, Laborate operates in 55 countries.
Trending
- Toyota Expands Nvidia AI Partnership Beyond Self-Driving Cars to Smart Cities and Factories
- Toyota and Nvidia Expand AI Partnership to Smart Cities, Factories and Mobility Infrastructure
- Zepto’s IPO Plans Move Ahead, But Profitability Concerns Weigh on Valuation
- China’s Moonshot AI Unveils Kimi K3 With 2.8 Trillion Parameters in Global AI Race
- China’s Moonshot AI Unveils Kimi K3 With 2.8 Trillion Parameters in Global AI Race
- OnePlus to Stop New Product Launches in the US and Europe, Says India Business Will Continue as Usual
- OnePlus to Stop New Product Launches in the US and Europe, Says India Business Will Continue as Usual
- Google Play Opens to Third-Party Android App Stores in US
Laborate Pharmaceutical’s Aqualab achieves ₹100 crore revenue, eyes ₹250 crore with retail-first model
Explore On The Go !
Deccan Founders © 2026 – All Rights Reserved